Thrivent Financial for Lutherans Has $2.54 Million Stake in Teleflex Incorporated (NYSE:TFX)

Thrivent Financial for Lutherans reduced its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 32.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,288 shares of the medical technology company's stock after selling 7,015 shares during the quarter. Thrivent Financial for Lutherans' holdings in Teleflex were worth $2,543,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in TFX. True Wealth Design LLC boosted its position in shares of Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after purchasing an additional 166 shares during the period. Avior Wealth Management LLC boosted its holdings in shares of Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after buying an additional 125 shares during the period. IFP Advisors Inc increased its position in shares of Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC raised its holdings in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares during the period. Finally, R Squared Ltd purchased a new stake in shares of Teleflex in the 4th quarter valued at approximately $64,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Teleflex Stock Up 0.3 %

Shares of TFX traded up $0.42 during mid-day trading on Monday, hitting $138.22. 1,109,221 shares of the company's stock were exchanged, compared to its average volume of 581,347. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91. The firm has a fifty day moving average of $158.33 and a two-hundred day moving average of $189.25. The stock has a market cap of $6.41 billion, a price-to-earnings ratio of 27.48, a P/E/G ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.98%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Ratings Changes

Several analysts have issued reports on TFX shares. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and lowered their target price for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Finally, Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.